These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1053 related articles for article (PubMed ID: 30551529)
1. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway. Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529 [TBL] [Abstract][Full Text] [Related]
2. Desumoylating Isopeptidase 2 (DESI2) Inhibits Proliferation and Promotes Apoptosis of Pancreatic Cancer Cells through Regulating PI3K/AKT/mTOR Signaling Pathway. Ou X; Zhang GT; Xu Z; Chen JS; Xie Y; Liu JK; Liu XP Pathol Oncol Res; 2019 Apr; 25(2):635-646. PubMed ID: 30411297 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway. Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X Gene; 2019 May; 698():50-60. PubMed ID: 30822475 [TBL] [Abstract][Full Text] [Related]
4. PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells. Liu S; Wang XJ; Liu Y; Cui YF Am J Chin Med; 2013; 41(3):629-42. PubMed ID: 23711146 [TBL] [Abstract][Full Text] [Related]
5. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway. Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839 [TBL] [Abstract][Full Text] [Related]
6. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN. Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796 [TBL] [Abstract][Full Text] [Related]
7. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1. Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401 [TBL] [Abstract][Full Text] [Related]
8. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation. Zhu J; Lv J; Chen J; Zhang X; Ji Y Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959 [No Abstract] [Full Text] [Related]
9. Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells. Xu Z; Zhang Y; Jiang J; Yang Y; Shi R; Hao B; Zhang Z; Huang Z; Kim JW; Zhang G BMC Cancer; 2010 Apr; 10():161. PubMed ID: 20423485 [TBL] [Abstract][Full Text] [Related]
10. Cucurmosin induces apoptosis of BxPC-3 human pancreatic cancer cells via inactivation of the EGFR signaling pathway. Zhang B; Huang H; Xie J; Xu C; Chen M; Wang C; Yang A; Yin Q Oncol Rep; 2012 Mar; 27(3):891-7. PubMed ID: 22139427 [TBL] [Abstract][Full Text] [Related]
11. Effect of STK3 on proliferation and apoptosis of pancreatic cancer cells via PI3K/AKT/mTOR pathway. Chen J; Liu F; Wu J; Yang Y; He J; Wu F; Yang K; Li J; Jiang Z; Jiang Z Cell Signal; 2023 Jun; 106():110642. PubMed ID: 36871796 [TBL] [Abstract][Full Text] [Related]
12. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis. Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252 [TBL] [Abstract][Full Text] [Related]
13. KRAS gene silencing inhibits the activation of PI3K-Akt-mTOR signaling pathway to regulate breast cancer cell epithelial-mesenchymal transition, proliferation and apoptosis. Zhang Y; Liu JL; Wang J Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3085-3096. PubMed ID: 32271426 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway. Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851 [TBL] [Abstract][Full Text] [Related]
15. Thymoquinone affects hypoxia-inducible factor-1α expression in pancreatic cancer cells via HSP90 and PI3K/AKT/mTOR pathways. Zhao ZX; Li S; Liu LX World J Gastroenterol; 2024 Jun; 30(21):2793-2816. PubMed ID: 38899332 [TBL] [Abstract][Full Text] [Related]
16. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y; Li S; Li J; Wang D; Li Q Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway. Wang Q; Zhang X; Song X; Zhang L Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142 [TBL] [Abstract][Full Text] [Related]
18. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway. Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667 [TBL] [Abstract][Full Text] [Related]
19. STK33 Promotes the Growth and Progression of Human Pancreatic Neuroendocrine Tumour via Activation of the PI3K/AKT/mTOR Pathway. Zhou B; Xiang J; Zhan C; Liu J; Yan S Neuroendocrinology; 2020; 110(3-4):307-320. PubMed ID: 31261148 [TBL] [Abstract][Full Text] [Related]
20. Mitofusin2 Induces Cell Autophagy of Pancreatic Cancer through Inhibiting the PI3K/Akt/mTOR Signaling Pathway. Xue R; Meng Q; Lu D; Liu X; Wang Y; Hao J Oxid Med Cell Longev; 2018; 2018():2798070. PubMed ID: 30046371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]